ADPT
Price
$13.13
Change
+$0.31 (+2.42%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
1.95B
35 days until earnings call
FULC
Price
$8.52
Change
+$0.27 (+3.27%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
446.26M
48 days until earnings call
Interact to see
Advertisement

ADPT vs FULC

Header iconADPT vs FULC Comparison
Open Charts ADPT vs FULCBanner chart's image
Adaptive Biotechnologies
Price$13.13
Change+$0.31 (+2.42%)
Volume$34.24K
Capitalization1.95B
Fulcrum Therapeutics
Price$8.52
Change+$0.27 (+3.27%)
Volume$4.73K
Capitalization446.26M
ADPT vs FULC Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. FULC commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Buy and FULC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ADPT: $12.82 vs. FULC: $8.25)
Brand notoriety: ADPT: Notable vs. FULC: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 87% vs. FULC: 76%
Market capitalization -- ADPT: $1.95B vs. FULC: $446.26M
ADPT [@Biotechnology] is valued at $1.95B. FULC’s [@Biotechnology] market capitalization is $446.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ADPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 3 TA indicator(s) are bullish while FULC’s TA Score has 6 bullish TA indicator(s).

  • ADPT’s TA Score: 3 bullish, 4 bearish.
  • FULC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а 0.00% price change this week, while FULC (@Biotechnology) price change was +12.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.96%. For the same industry, the average monthly price growth was +8.68%, and the average quarterly price growth was +48.56%.

Reported Earning Dates

ADPT is expected to report earnings on Oct 30, 2025.

FULC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($1.95B) has a higher market cap than FULC($446M). ADPT YTD gains are higher at: 113.845 vs. FULC (75.532). FULC has higher annual earnings (EBITDA): -81.28M vs. ADPT (-91.22M). FULC has more cash in the bank: 214M vs. ADPT (198M). FULC has less debt than ADPT: FULC (7.57M) vs ADPT (84.4M). ADPT has higher revenues than FULC: ADPT (205M) vs FULC (0).
ADPTFULCADPT / FULC
Capitalization1.95B446M438%
EBITDA-91.22M-81.28M112%
Gain YTD113.84575.532151%
P/E RatioN/AN/A-
Revenue205M0-
Total Cash198M214M93%
Total Debt84.4M7.57M1,115%
FUNDAMENTALS RATINGS
ADPT vs FULC: Fundamental Ratings
ADPT
FULC
OUTLOOK RATING
1..100
6612
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3738
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3224

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (24) in the null industry is somewhat better than the same rating for ADPT (60) in the Hospital Or Nursing Management industry. This means that FULC’s stock grew somewhat faster than ADPT’s over the last 12 months.

FULC's Profit vs Risk Rating (96) in the null industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that FULC’s stock grew similarly to ADPT’s over the last 12 months.

FULC's SMR Rating (97) in the null industry is in the same range as ADPT (98) in the Hospital Or Nursing Management industry. This means that FULC’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's Price Growth Rating (37) in the Hospital Or Nursing Management industry is in the same range as FULC (38) in the null industry. This means that ADPT’s stock grew similarly to FULC’s over the last 12 months.

ADPT's P/E Growth Rating (100) in the Hospital Or Nursing Management industry is in the same range as FULC (100) in the null industry. This means that ADPT’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTFULC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGISX18.52N/A
N/A
Nationwide BNY Mellon Dyn US Core I.S
TGVRX31.83N/A
N/A
Thornburg International Equity R3
LVOCX14.68N/A
N/A
Lord Abbett Value Opportunities C
BRSVX39.24N/A
N/A
Bridgeway Small-Cap Value
MSSCX9.48N/A
N/A
AMG Frontier Small Cap Growth I

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ADPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+12.24%
ADPT - FULC
48%
Loosely correlated
-7.97%
SLS - FULC
48%
Loosely correlated
-4.12%
ARWR - FULC
46%
Loosely correlated
+1.02%
BEAM - FULC
45%
Loosely correlated
-0.59%
TRDA - FULC
45%
Loosely correlated
+1.18%
More